Astria Therapeutics Inc
ATXS
Get informed when a big investor buys or sells
+ FollowMarket Cap$718.13M
Close$
$0.97
92.3% downside
Current Fair Value
92.3% downsideOvervalued by 92.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $718.13 Million |
|---|---|
| Enterprise Value | $630.80 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.68 |
| Beta | 0.02 |
| Outstanding Shares | 58,005,312 |
Return
| Return on Equity | -53.17% |
|---|---|
| Return on Assets | -45.62% |
| Return on Invested Capital | -54.95% |
Valuation & Multiples
| P/E Ratio | -5.88 |
|---|---|
| PEG | -20.3 |
| Price to Sales | - |
| Price to Book Ratio | 3.15 |
| Enterprise Value to Revenue | 893.49 |
| Enterprise Value to EBIT | -4.62 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
November 12, 2025
EPS Estimate
$-0.41
Average shareholder expectationRevenue Estimate
$10.67 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 127.11% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | 19,600▼ 64.87% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 97.45%▼ 1.84% |
|---|---|
| Total Invested | $738.20M▲ 80.43% |
| Investors Holding | 141▲ 20.00% |
ESG Score
No data
About Astria Therapeutics Inc
20 employees